Rethinking Routers: A Fresh Take

With our company’s three plus decades of cellular expertise, millions of field-deployed devices, and a relentless drive to innovate, our family of routers have quite the history. From the early days of 2G, deep into the 5G era, two factors have consistently guided us: providing the ultimate in performance while ensuring longevity and reliability. From…

Moderna soars on analyst upgrade

Moderna (NASDAQ: MRNA) saw its stock surge 13% after Oppenheimer & Co. (NYSE: OPY) analyst Hartaj Singh upgraded the stock to “outperform” and predicted five product approvals by 2026. This comes despite a dismal 2023 for the company, marked by declining COVID-19 vaccine sales and investor concerns about pipeline progress. Moderna Inc. is a pioneering…